QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 azitra-receives-study-may-proceed-letter-from-the-fda-for-ind-to-treat-skin-rash-from-egfr-inhibitors

New investigational new drug (IND) application cleared to proceed by the US FDA for a Phase 1/2 clinical study of ATR-04 for mo...

 anitra-q2-2024-gaap-eps-274-misses-036-estimate-sales-75000k-down-from-172000k-yoy

Anitra (AMEX:AZTR) reported quarterly losses of $(2.74) per share which missed the analyst consensus estimate of $(0.36) by 661...

 azitra-shares-resumed-trade
Azitra Shares Resumed Trade
08/09/2024 15:15:59

 why-azitra-stock-is-crashing
Why Azitra Stock Is Crashing
07/24/2024 16:44:45

Azitra shares are crashing Wednesday after the company announced the pricing of a $10 million public offering of 6,665,000 comm...

 why-azitra-stock-is-moving-higher-on-tuesday

Azitra announced that the U.S. Patent and Trademark Office granted it's patent application regarding the treatment of atopi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION